Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Apheresis Equipment Market by Process Type (Plateletpheresis, Leukapheresis, Plasmapheresis, Erythrocytapheresis, Others), by Product Type (Disposables, Devices), by Application (Blood Collection, Treatment) and by Technology (Centrifugation, Membrane Filtration): Global Opportunity Analysis and Industry Forecast, 2023-2032

A01156

Pages: NA

Charts: NA

Tables: NA

Apheresis is a process in which the blood is temporarily drawn from a donor and separated into its components. Further, the required components like plasma or platelets are retained and the remaining blood is returned to the donor by transfusion. Apheresis is used to separate the required blood components, from the donors blood and is also used in the treatment of particular conditions like leukemia. Blood platelets are used in the treatment of various diseases and are extracted using the apheresis equipment. A rise in the demand for blood derivatives, increasing incidences of conditions like sickle cell anemia and leukemia along with the increasing use of apheresis to treat cancer, are the key factors, which would drive the growth of global apheresis equipment market during the analysis period. Presently, the market witnesses a larger adoption of disposable apheresis kits arising from the high incidence rates of hospital acquired infections. This would further drive the growth of global apheresis equipment market. A key factor that restrains the growth of this market is the lack of blood donors.

The global apheresis equipment market, is segmented on the basis of Process Type, Product type, Application, Technology and Geography. The process type considered in this report include Plateletpheresis, Leukapheresis, Plasmapheresis, Erythrocytapheresis and Others (Photopheresis, LDL (low-density lipoprotein) apheresis). Based on product type, the market is classified into Disposables and Devices. Based on application, the market is classified into Blood Collection and Treatment. The treatment application is further classified into Neurology, Haematology, Renal diseases and others. Based on technology, the market is classified into Centrifugation and Membrane Filtration. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific and LAMEA. One of the key strategies adopted by major market players is acquisition. For instance, Terumo Corporation acquired CaridianBCT in 2011. With this takeover, Terumo Corporation emerged as a leading player in the apheresis equipment market. The companies profiled in this report are Cerus Corporation, Fresenius Medical Care, Asahi Kasei Medical, Fenwal, Kawasumi Laboratories, Haemonetics Corporation, Terumo Bct, Kaneka Corporation, Hemacare Corporation and Therakos.

KEY MARKET BENEFITS:

  • The report provides a quantitative analysis of the current market and estimations which would enable the stakeholders to capitalize on prevailing market opportunities
  • Extensive analysis of the global apheresis equipment market by product type helps in understanding the types of equipment that are currently used along with the variants that would gain prominence in future
  • Competitive intelligence highlights the business practices followed by leading market players across various geographies
  • Comprehensive analysis of factors that drive and restrict the growth of the global apheresis equipment market is provided
  • SWOT analysis highlights the internal environment of leading companies for effective strategy formulation
  • The apheresis equipment market scenario is comprehensively analysed in accordance to the key regions

Key Market Segments

  • By Process Type
    • Plateletpheresis
    • Leukapheresis
    • Plasmapheresis
    • Erythrocytapheresis
    • Others
  • By Product Type
    • Disposables
    • Devices
  • By Application
    • Blood Collection
    • Treatment
      • Neurology
      • Haematology
      • Renal diseases
      • Other
  • By Technology
    • Centrifugation
    • Membrane Filtration
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Therakos
  • Kawasumi Laboratories
  • Hemacare Corporation
  • Kaneka Corporation
  • Fresenius Medical Care
  • Haemonetics Corporation
  • Cerus Corporation
  • Fenwal
  • Terumo Bct
  • Asahi Kasei Medical
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: APHERESIS EQUIPMENT MARKET, BY PROCESS TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Process Type

    • 4.2. Plateletpheresis

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Leukapheresis

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Plasmapheresis

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Erythrocytapheresis

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: APHERESIS EQUIPMENT MARKET, BY PRODUCT TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Product Type

    • 5.2. Disposables

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Devices

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: APHERESIS EQUIPMENT MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Blood Collection

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Treatment

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

      • 6.3.4. Neurology

        • 6.3.4.1. Market Size and Forecast
      • 6.3.4. Haematology

        • 6.3.4.1. Market Size and Forecast
      • 6.3.4. Renal diseases

        • 6.3.4.1. Market Size and Forecast
      • 6.3.4. Other

        • 6.3.4.1. Market Size and Forecast
  • CHAPTER 7: APHERESIS EQUIPMENT MARKET, BY TECHNOLOGY

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Technology

    • 7.2. Centrifugation

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Membrane Filtration

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

  • CHAPTER 8: APHERESIS EQUIPMENT MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Process Type

      • 8.2.3. Market Size and Forecast, By Product Type

      • 8.2.4. Market Size and Forecast, By Application

      • 8.2.5. Market Size and Forecast, By Technology

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Apheresis Equipment Market

        • 8.2.7.1. Market Size and Forecast, By Process Type
        • 8.2.7.2. Market Size and Forecast, By Product Type
        • 8.2.7.3. Market Size and Forecast, By Application
        • 8.2.7.4. Market Size and Forecast, By Technology
      • 8.2.8. Canada Apheresis Equipment Market

        • 8.2.8.1. Market Size and Forecast, By Process Type
        • 8.2.8.2. Market Size and Forecast, By Product Type
        • 8.2.8.3. Market Size and Forecast, By Application
        • 8.2.8.4. Market Size and Forecast, By Technology
      • 8.2.9. Mexico Apheresis Equipment Market

        • 8.2.9.1. Market Size and Forecast, By Process Type
        • 8.2.9.2. Market Size and Forecast, By Product Type
        • 8.2.9.3. Market Size and Forecast, By Application
        • 8.2.9.4. Market Size and Forecast, By Technology
    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Process Type

      • 8.3.3. Market Size and Forecast, By Product Type

      • 8.3.4. Market Size and Forecast, By Application

      • 8.3.5. Market Size and Forecast, By Technology

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Apheresis Equipment Market

        • 8.3.7.1. Market Size and Forecast, By Process Type
        • 8.3.7.2. Market Size and Forecast, By Product Type
        • 8.3.7.3. Market Size and Forecast, By Application
        • 8.3.7.4. Market Size and Forecast, By Technology
      • 8.3.8. Germany Apheresis Equipment Market

        • 8.3.8.1. Market Size and Forecast, By Process Type
        • 8.3.8.2. Market Size and Forecast, By Product Type
        • 8.3.8.3. Market Size and Forecast, By Application
        • 8.3.8.4. Market Size and Forecast, By Technology
      • 8.3.9. Italy Apheresis Equipment Market

        • 8.3.9.1. Market Size and Forecast, By Process Type
        • 8.3.9.2. Market Size and Forecast, By Product Type
        • 8.3.9.3. Market Size and Forecast, By Application
        • 8.3.9.4. Market Size and Forecast, By Technology
      • 8.3.10. Spain Apheresis Equipment Market

        • 8.3.10.1. Market Size and Forecast, By Process Type
        • 8.3.10.2. Market Size and Forecast, By Product Type
        • 8.3.10.3. Market Size and Forecast, By Application
        • 8.3.10.4. Market Size and Forecast, By Technology
      • 8.3.11. UK Apheresis Equipment Market

        • 8.3.11.1. Market Size and Forecast, By Process Type
        • 8.3.11.2. Market Size and Forecast, By Product Type
        • 8.3.11.3. Market Size and Forecast, By Application
        • 8.3.11.4. Market Size and Forecast, By Technology
      • 8.3.12. Russia Apheresis Equipment Market

        • 8.3.12.1. Market Size and Forecast, By Process Type
        • 8.3.12.2. Market Size and Forecast, By Product Type
        • 8.3.12.3. Market Size and Forecast, By Application
        • 8.3.12.4. Market Size and Forecast, By Technology
      • 8.3.13. Rest Of Europe Apheresis Equipment Market

        • 8.3.13.1. Market Size and Forecast, By Process Type
        • 8.3.13.2. Market Size and Forecast, By Product Type
        • 8.3.13.3. Market Size and Forecast, By Application
        • 8.3.13.4. Market Size and Forecast, By Technology
    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Process Type

      • 8.4.3. Market Size and Forecast, By Product Type

      • 8.4.4. Market Size and Forecast, By Application

      • 8.4.5. Market Size and Forecast, By Technology

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Apheresis Equipment Market

        • 8.4.7.1. Market Size and Forecast, By Process Type
        • 8.4.7.2. Market Size and Forecast, By Product Type
        • 8.4.7.3. Market Size and Forecast, By Application
        • 8.4.7.4. Market Size and Forecast, By Technology
      • 8.4.8. Japan Apheresis Equipment Market

        • 8.4.8.1. Market Size and Forecast, By Process Type
        • 8.4.8.2. Market Size and Forecast, By Product Type
        • 8.4.8.3. Market Size and Forecast, By Application
        • 8.4.8.4. Market Size and Forecast, By Technology
      • 8.4.9. India Apheresis Equipment Market

        • 8.4.9.1. Market Size and Forecast, By Process Type
        • 8.4.9.2. Market Size and Forecast, By Product Type
        • 8.4.9.3. Market Size and Forecast, By Application
        • 8.4.9.4. Market Size and Forecast, By Technology
      • 8.4.10. South Korea Apheresis Equipment Market

        • 8.4.10.1. Market Size and Forecast, By Process Type
        • 8.4.10.2. Market Size and Forecast, By Product Type
        • 8.4.10.3. Market Size and Forecast, By Application
        • 8.4.10.4. Market Size and Forecast, By Technology
      • 8.4.11. Australia Apheresis Equipment Market

        • 8.4.11.1. Market Size and Forecast, By Process Type
        • 8.4.11.2. Market Size and Forecast, By Product Type
        • 8.4.11.3. Market Size and Forecast, By Application
        • 8.4.11.4. Market Size and Forecast, By Technology
      • 8.4.12. Thailand Apheresis Equipment Market

        • 8.4.12.1. Market Size and Forecast, By Process Type
        • 8.4.12.2. Market Size and Forecast, By Product Type
        • 8.4.12.3. Market Size and Forecast, By Application
        • 8.4.12.4. Market Size and Forecast, By Technology
      • 8.4.13. Malaysia Apheresis Equipment Market

        • 8.4.13.1. Market Size and Forecast, By Process Type
        • 8.4.13.2. Market Size and Forecast, By Product Type
        • 8.4.13.3. Market Size and Forecast, By Application
        • 8.4.13.4. Market Size and Forecast, By Technology
      • 8.4.14. Indonesia Apheresis Equipment Market

        • 8.4.14.1. Market Size and Forecast, By Process Type
        • 8.4.14.2. Market Size and Forecast, By Product Type
        • 8.4.14.3. Market Size and Forecast, By Application
        • 8.4.14.4. Market Size and Forecast, By Technology
      • 8.4.15. Rest of Asia Pacific Apheresis Equipment Market

        • 8.4.15.1. Market Size and Forecast, By Process Type
        • 8.4.15.2. Market Size and Forecast, By Product Type
        • 8.4.15.3. Market Size and Forecast, By Application
        • 8.4.15.4. Market Size and Forecast, By Technology
    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Process Type

      • 8.5.3. Market Size and Forecast, By Product Type

      • 8.5.4. Market Size and Forecast, By Application

      • 8.5.5. Market Size and Forecast, By Technology

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Apheresis Equipment Market

        • 8.5.7.1. Market Size and Forecast, By Process Type
        • 8.5.7.2. Market Size and Forecast, By Product Type
        • 8.5.7.3. Market Size and Forecast, By Application
        • 8.5.7.4. Market Size and Forecast, By Technology
      • 8.5.8. South Africa Apheresis Equipment Market

        • 8.5.8.1. Market Size and Forecast, By Process Type
        • 8.5.8.2. Market Size and Forecast, By Product Type
        • 8.5.8.3. Market Size and Forecast, By Application
        • 8.5.8.4. Market Size and Forecast, By Technology
      • 8.5.9. Saudi Arabia Apheresis Equipment Market

        • 8.5.9.1. Market Size and Forecast, By Process Type
        • 8.5.9.2. Market Size and Forecast, By Product Type
        • 8.5.9.3. Market Size and Forecast, By Application
        • 8.5.9.4. Market Size and Forecast, By Technology
      • 8.5.10. UAE Apheresis Equipment Market

        • 8.5.10.1. Market Size and Forecast, By Process Type
        • 8.5.10.2. Market Size and Forecast, By Product Type
        • 8.5.10.3. Market Size and Forecast, By Application
        • 8.5.10.4. Market Size and Forecast, By Technology
      • 8.5.11. Argentina Apheresis Equipment Market

        • 8.5.11.1. Market Size and Forecast, By Process Type
        • 8.5.11.2. Market Size and Forecast, By Product Type
        • 8.5.11.3. Market Size and Forecast, By Application
        • 8.5.11.4. Market Size and Forecast, By Technology
      • 8.5.12. Rest of LAMEA Apheresis Equipment Market

        • 8.5.12.1. Market Size and Forecast, By Process Type
        • 8.5.12.2. Market Size and Forecast, By Product Type
        • 8.5.12.3. Market Size and Forecast, By Application
        • 8.5.12.4. Market Size and Forecast, By Technology
  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning, 2024

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Cerus Corporation

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Fresenius Medical Care

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Asahi Kasei Medical

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Fenwal

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Kawasumi Laboratories

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Haemonetics Corporation

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Terumo Bct

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Kaneka Corporation

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Hemacare Corporation

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Therakos

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL APHERESIS EQUIPMENT MARKET, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL APHERESIS EQUIPMENT MARKET FOR PLATELETPHERESIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL APHERESIS EQUIPMENT MARKET FOR LEUKAPHERESIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL APHERESIS EQUIPMENT MARKET FOR PLASMAPHERESIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL APHERESIS EQUIPMENT MARKET FOR ERYTHROCYTAPHERESIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL APHERESIS EQUIPMENT MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL APHERESIS EQUIPMENT MARKET, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL APHERESIS EQUIPMENT MARKET FOR DISPOSABLES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL APHERESIS EQUIPMENT MARKET FOR DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL APHERESIS EQUIPMENT MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL APHERESIS EQUIPMENT MARKET FOR BLOOD COLLECTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL APHERESIS EQUIPMENT MARKET FOR TREATMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL APHERESIS EQUIPMENT MARKET, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL APHERESIS EQUIPMENT MARKET FOR CENTRIFUGATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL APHERESIS EQUIPMENT MARKET FOR MEMBRANE FILTRATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL APHERESIS EQUIPMENT MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA APHERESIS EQUIPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 22. U.S. APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 23. U.S. APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 24. U.S. APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. U.S. APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 26. CANADA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 27. CANADA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 28. CANADA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. CANADA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 30. MEXICO APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 31. MEXICO APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 32. MEXICO APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. MEXICO APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 34. EUROPE APHERESIS EQUIPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 35. EUROPE APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 36. EUROPE APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 37. EUROPE APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. EUROPE APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 39. FRANCE APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 40. FRANCE APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 41. FRANCE APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. FRANCE APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 43. GERMANY APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 44. GERMANY APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 45. GERMANY APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. GERMANY APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 47. ITALY APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 48. ITALY APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 49. ITALY APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. ITALY APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 51. SPAIN APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 52. SPAIN APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 53. SPAIN APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. SPAIN APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 55. UK APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 56. UK APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 57. UK APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. UK APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 59. RUSSIA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 60. RUSSIA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 61. RUSSIA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. RUSSIA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 63. REST OF EUROPE APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 64. REST OF EUROPE APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 65. REST OF EUROPE APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. REST OF EUROPE APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 67. ASIA-PACIFIC APHERESIS EQUIPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 68. ASIA-PACIFIC APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 69. ASIA-PACIFIC APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 70. ASIA-PACIFIC APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. ASIA-PACIFIC APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 72. CHINA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 73. CHINA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 74. CHINA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. CHINA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 76. JAPAN APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 77. JAPAN APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 78. JAPAN APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 79. JAPAN APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 80. INDIA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 81. INDIA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 82. INDIA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 83. INDIA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 84. SOUTH KOREA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 85. SOUTH KOREA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 86. SOUTH KOREA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 87. SOUTH KOREA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 88. AUSTRALIA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 89. AUSTRALIA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 90. AUSTRALIA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 91. AUSTRALIA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 92. THAILAND APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 93. THAILAND APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 94. THAILAND APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 95. THAILAND APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 96. MALAYSIA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 97. MALAYSIA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 98. MALAYSIA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 99. MALAYSIA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 100. INDONESIA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 101. INDONESIA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 102. INDONESIA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 103. INDONESIA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 104. REST OF ASIA PACIFIC APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 105. REST OF ASIA PACIFIC APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 106. REST OF ASIA PACIFIC APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 107. REST OF ASIA PACIFIC APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 108. LAMEA APHERESIS EQUIPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 109. LAMEA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 110. LAMEA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 111. LAMEA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 112. LAMEA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 113. BRAZIL APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 114. BRAZIL APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 115. BRAZIL APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 116. BRAZIL APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 117. SOUTH AFRICA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 118. SOUTH AFRICA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 119. SOUTH AFRICA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 120. SOUTH AFRICA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 121. SAUDI ARABIA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 122. SAUDI ARABIA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 123. SAUDI ARABIA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 124. SAUDI ARABIA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 125. UAE APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 126. UAE APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 127. UAE APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 128. UAE APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 129. ARGENTINA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 130. ARGENTINA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 131. ARGENTINA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 132. ARGENTINA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 133. REST OF LAMEA APHERESIS EQUIPMENT, BY PROCESS TYPE, 2025-2033 ($MILLION)
  • TABLE 134. REST OF LAMEA APHERESIS EQUIPMENT, BY PRODUCT TYPE, 2025-2033 ($MILLION)
  • TABLE 135. REST OF LAMEA APHERESIS EQUIPMENT, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 136. REST OF LAMEA APHERESIS EQUIPMENT, BY TECHNOLOGY, 2025-2033 ($MILLION)
  • TABLE 137. CERUS CORPORATION: KEY EXECUTIVES
  • TABLE 138. CERUS CORPORATION: COMPANY SNAPSHOT
  • TABLE 139. CERUS CORPORATION: OPERATING SEGMENTS
  • TABLE 140. CERUS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 141. CERUS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. FRESENIUS MEDICAL CARE: KEY EXECUTIVES
  • TABLE 143. FRESENIUS MEDICAL CARE: COMPANY SNAPSHOT
  • TABLE 144. FRESENIUS MEDICAL CARE: OPERATING SEGMENTS
  • TABLE 145. FRESENIUS MEDICAL CARE: PRODUCT PORTFOLIO
  • TABLE 146. FRESENIUS MEDICAL CARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. ASAHI KASEI MEDICAL: KEY EXECUTIVES
  • TABLE 148. ASAHI KASEI MEDICAL: COMPANY SNAPSHOT
  • TABLE 149. ASAHI KASEI MEDICAL: OPERATING SEGMENTS
  • TABLE 150. ASAHI KASEI MEDICAL: PRODUCT PORTFOLIO
  • TABLE 151. ASAHI KASEI MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. FENWAL: KEY EXECUTIVES
  • TABLE 153. FENWAL: COMPANY SNAPSHOT
  • TABLE 154. FENWAL: OPERATING SEGMENTS
  • TABLE 155. FENWAL: PRODUCT PORTFOLIO
  • TABLE 156. FENWAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. KAWASUMI LABORATORIES: KEY EXECUTIVES
  • TABLE 158. KAWASUMI LABORATORIES: COMPANY SNAPSHOT
  • TABLE 159. KAWASUMI LABORATORIES: OPERATING SEGMENTS
  • TABLE 160. KAWASUMI LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 161. KAWASUMI LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 162. HAEMONETICS CORPORATION: KEY EXECUTIVES
  • TABLE 163. HAEMONETICS CORPORATION: COMPANY SNAPSHOT
  • TABLE 164. HAEMONETICS CORPORATION: OPERATING SEGMENTS
  • TABLE 165. HAEMONETICS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 166. HAEMONETICS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 167. TERUMO BCT: KEY EXECUTIVES
  • TABLE 168. TERUMO BCT: COMPANY SNAPSHOT
  • TABLE 169. TERUMO BCT: OPERATING SEGMENTS
  • TABLE 170. TERUMO BCT: PRODUCT PORTFOLIO
  • TABLE 171. TERUMO BCT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 172. KANEKA CORPORATION: KEY EXECUTIVES
  • TABLE 173. KANEKA CORPORATION: COMPANY SNAPSHOT
  • TABLE 174. KANEKA CORPORATION: OPERATING SEGMENTS
  • TABLE 175. KANEKA CORPORATION: PRODUCT PORTFOLIO
  • TABLE 176. KANEKA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 177. HEMACARE CORPORATION: KEY EXECUTIVES
  • TABLE 178. HEMACARE CORPORATION: COMPANY SNAPSHOT
  • TABLE 179. HEMACARE CORPORATION: OPERATING SEGMENTS
  • TABLE 180. HEMACARE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 181. HEMACARE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 182. THERAKOS: KEY EXECUTIVES
  • TABLE 183. THERAKOS: COMPANY SNAPSHOT
  • TABLE 184. THERAKOS: OPERATING SEGMENTS
  • TABLE 185. THERAKOS: PRODUCT PORTFOLIO
  • TABLE 186. THERAKOS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL APHERESIS EQUIPMENT MARKET SEGMENTATION
  • FIGURE 2. GLOBAL APHERESIS EQUIPMENT MARKET
  • FIGURE 3. SEGMENTATION APHERESIS EQUIPMENT MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN APHERESIS EQUIPMENT MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALAPHERESIS EQUIPMENT MARKET
  • FIGURE 11. APHERESIS EQUIPMENT MARKET SEGMENTATION, BY BY PROCESS TYPE
  • FIGURE 12. APHERESIS EQUIPMENT MARKET FOR PLATELETPHERESIS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. APHERESIS EQUIPMENT MARKET FOR LEUKAPHERESIS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. APHERESIS EQUIPMENT MARKET FOR PLASMAPHERESIS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. APHERESIS EQUIPMENT MARKET FOR ERYTHROCYTAPHERESIS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. APHERESIS EQUIPMENT MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. APHERESIS EQUIPMENT MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 18. APHERESIS EQUIPMENT MARKET FOR DISPOSABLES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. APHERESIS EQUIPMENT MARKET FOR DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. APHERESIS EQUIPMENT MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 21. APHERESIS EQUIPMENT MARKET FOR BLOOD COLLECTION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. APHERESIS EQUIPMENT MARKET FOR TREATMENT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. APHERESIS EQUIPMENT MARKET SEGMENTATION, BY BY TECHNOLOGY
  • FIGURE 24. APHERESIS EQUIPMENT MARKET FOR CENTRIFUGATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. APHERESIS EQUIPMENT MARKET FOR MEMBRANE FILTRATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: APHERESIS EQUIPMENT MARKET
  • FIGURE 32. TOP PLAYER POSITIONING, 2024
  • FIGURE 33. CERUS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. CERUS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. CERUS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. FRESENIUS MEDICAL CARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. FRESENIUS MEDICAL CARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. FRESENIUS MEDICAL CARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. ASAHI KASEI MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. ASAHI KASEI MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. ASAHI KASEI MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. FENWAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. FENWAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. FENWAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. KAWASUMI LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. KAWASUMI LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. KAWASUMI LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. HAEMONETICS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. HAEMONETICS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. HAEMONETICS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. TERUMO BCT: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. TERUMO BCT: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. TERUMO BCT: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. KANEKA CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. KANEKA CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. KANEKA CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. HEMACARE CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. HEMACARE CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. HEMACARE CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 60. THERAKOS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 61. THERAKOS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 62. THERAKOS: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Apheresis Equipment Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue